These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 902380)

  • 1. Individualized values for the disappearance rate parameter (Kd) in the enzymatic estimation of infarct size. A critique.
    Slutsky AS
    Circulation; 1977 Oct; 56(4 Pt 1):545-7. PubMed ID: 902380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved basis for enzymatic estimation of infarct size.
    Roberts R; Henry PD; Sobel BE
    Circulation; 1975 Nov; 52(5):743-54. PubMed ID: 1236776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of ischemic injury.
    Shell WE; Sobel BE
    Circulation; 1976 Mar; 53(3 Suppl):I98-106. PubMed ID: 1253377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
    Shell WE; Kjekshus JK; Sobel BE
    J Clin Invest; 1971 Dec; 50(12):2614-25. PubMed ID: 5129313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction size from serial CPK: variability of CPK serum entry ratio with size and model of infarction.
    Cairns JA; Missirlis E; Fallen EL
    Circulation; 1978 Dec; 58(6):1143-53. PubMed ID: 709770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between enzymatic and histologic estimates of the extent of myocardial infarction in conscious dogs with permanent coronary occlusion.
    Roe CR; Cobb FR; Starmer CF
    Circulation; 1977 Mar; 55(3):438-49. PubMed ID: 837480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations.
    Sobel BE; Roberts R; Larson KB
    Am J Cardiol; 1976 Mar; 37(4):474-85. PubMed ID: 1258784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations in the use of biochemical markers of ischemic injury.
    Sobel BE; Roberts R; Larson KB
    Circ Res; 1976 May; 38(5 Suppl 1):I99-108. PubMed ID: 1269094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.
    Jarmakani JM; Limbird L; Graham TC; Marks RA
    Cardiovasc Res; 1976 Mar; 10(2):245-53. PubMed ID: 938992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitivity analysis of enzymatic estimation of infarct size.
    Roe CR; Starmer CF
    Circulation; 1975 Jul; 52(1):1-5. PubMed ID: 1132111
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of enzymatic, anatomic and electrocardiographic estimates of myocardial infarct size in man.
    Ezaki H; Matsushita S; Ohkawa S; Kuramoto K
    Jpn Circ J; 1987 Apr; 51(4):374-82. PubMed ID: 3613040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved method for measuring the size of myocardial infarctions.
    Slutsky AS
    Med Hypotheses; 1975; 1(6):217-21. PubMed ID: 1228373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modifications fail to improve CPK estimates of extent of infarct.
    Roe CR; Starmer CF; Cobb FR
    Circulation; 1977 Apr; 55(4):678-9. PubMed ID: 837515
    [No Abstract]   [Full Text] [Related]  

  • 14. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
    Shell WE; Lavelle JF; Covell JW; Sobel BE
    J Clin Invest; 1973 Oct; 52(10):2579-90. PubMed ID: 4729051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of myocardial infarction with enzymatic indices.
    Ahumada G; Roberts R; Sobel BE
    Prog Cardiovasc Dis; 1976; 18(5):405-20. PubMed ID: 775531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial serum creatine phosphokinase MB isoenzyme activity after myocardial infarction. Studies in the baboon and man.
    Yasmineh WG; Pyle RB; Cohn JN; Nicoloff DM; Hanson NQ; Steele BW
    Circulation; 1977 May; 55(5):733-7. PubMed ID: 403031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of propranolol on canine myocardial CPK distribution space and rate of disappearance.
    Cairns JA; Klassen GA
    Circulation; 1977 Aug; 56(2):284-8. PubMed ID: 872323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial infarct size in clinical practice.
    Váchová J; Eglis M; Fidler V; Stanĕk V; Málek I; Pavlovic J; Gebauerová M; Bergmann K
    Cor Vasa; 1979; 21(6):387-97. PubMed ID: 546593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selected drugs and myocardial infarction on the disappearance of creatine kinase from the circulation in conscious dogs.
    Roberts R; Sobel BE
    Cardiovasc Res; 1977 Mar; 11(2):103-12. PubMed ID: 870194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calculation of mass of necrosis developing in the necrotic period of a myocardial infarct].
    Vinogradov AV; Glazunov AS; Aloev RS; Zhuravleva IA; Ianushkovskaia LA
    Kardiologiia; 1986 Dec; 26(12):32-6. PubMed ID: 3560608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.